Immune therapy doubles lung cancer survival rate

Credit: bizjournals- Published on April 17, 2018
New drugs that trigger a patient’s immune system to kill malignant cells can greatly improve the survival rate of people with the most common type of lung cancer, a new study found. The study, published in the New England Journal of Medicine, found that patients treated with the checkpoint inhibitor pembrolizumab, or Keytruda,...

You are here

Recent related videos from verified sources

'Jeopardy!' Host Alex Trebek Thanks Fans For Outpouring Of Support 01:05
Credit: Wochit Entertainment - Published 1 week ago 

Jeopardy's Alex Trebek Will Still Work—As He Fights Stage 4 Cancer 00:36
Credit: Wochit Entertainment - Published 2 weeks ago 

'Jeopardy!' Host Says He's Determined To Beat Stage Four Pancreatic Cancer 00:43
Credit: Wochit Entertainment - Published 2 weeks ago 

'Jeopardy!' Host Alex Trebek Announces His Fight With Stage 4 Pancreatic Cancer 00:49
Credit: Wochit - Published 2 weeks ago 

High Fiber Diets Can Help Cancer Treatments— Probiotics Don't 00:44
Credit: Wochit News - Published 3 weeks ago 

New Benefits Of Aspirin And Ibuprofen 00:32
Credit: Wochit - Published on January 28, 2019 

You might like